News

New heart valve guideline has more accessible format


 

FROM CIRCULATION AND THE JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dr. Nishimura and Dr. Otto reported no financial conflicts of interest; their associates on the ACC/AHA Task Force’s writing committee reported ties to Edwards Scientific, Medtronic, and St. Jude Medical.

Pages

Recommended Reading

CoreValve holds size advantage for U.S. TAVR
MDedge Internal Medicine
WOEST results guide antithrombotic therapy in PCI
MDedge Internal Medicine
Preoperative organ dysfunction worsens SAVR outcomes
MDedge Internal Medicine
FDA reviewers support approval of platelet inhibitor cangrelor for PCI indication
MDedge Internal Medicine
Mini-VADs could transform heart failure therapy
MDedge Internal Medicine
FDA panel votes against cangrelor approval for PCI, bridge indications
MDedge Internal Medicine
Ablation edges out drugs for treatment-naive paroxysmal atrial fibrillation
MDedge Internal Medicine
RAS blocker prescriptions still lag for ACS patients
MDedge Internal Medicine
Minimalist transfemoral TAVR winning surgical converts
MDedge Internal Medicine
Calculate an STS score before all aortic valve replacements
MDedge Internal Medicine